Ectopic adiposity and cardiometabolic health in COPD

References

• SavaFLavioletteLBernardSBretonMJBourbeauJMaltaisFThe impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPDBMC Pulm Med2010105521054892
   PubMed Web of Science ®Google Scholar
• RuttenEPCalverleyPMCasaburiRChanges in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?Ann Nutr Metab201363323924724216978
   PubMed Web of Science ®Google Scholar
• TchernofADesprésJPPathophysiology of human visceral obesity: an updatePhysiol Rev201393135940423303913
   PubMed Web of Science ®Google Scholar
• DesprésJPLemieuxIAbdominal obesity and metabolic syndromeNature2006444712188188717167477
   PubMed Web of Science ®Google Scholar
• MartinMAlmérasNDesprésJPEctopic fat accumulation in patients with COPD: an ECLIPSE substudyInt J Chron Obstruct Pulmon Dis20171245146028203068
   PubMed Web of Science ®Google Scholar
• van den BorstBGoskerHRKosterAThe influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung diseaseAm J Clin Nutr201296351652622811442
   PubMed Web of Science ®Google Scholar
• FurutateRIshiiTWakabayashiRExcessive visceral fat accumulation in advanced chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011642343021857782
   PubMed Web of Science ®Google Scholar
• RoversiSFabbriLMSinDDHawkinsNMAgustíAChronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated CareAm J Respir Crit Care Med2016194111319133627589227
   PubMed Web of Science ®Google Scholar
• ChenWThomasJSadatsafaviMFitzgeraldJMRisk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisLancet Respir Med20153863163926208998
   PubMed Web of Science ®Google Scholar
• BoltonCEEvansMIonescuAAInsulin resistance and inflammation – A further systemic complication of COPDCOPD20074212112617530505
   PubMedGoogle Scholar
• HershCPMakeBJLynchDANon-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitusBMC Pulm Med20141416425341556
   PubMed Web of Science ®Google Scholar
• VestboJAndersonJABrookRDFluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trialLancet2016387100301817182627203508
   PubMed Web of Science ®Google Scholar
• BourbeauJTanWCBenedettiACanadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPDCOPD201411212513222433011
   PubMedGoogle Scholar
• DesprésJPRossRBokaGAlmérasNLemieuxIADAGIO-Lipids InvestigatorsEffect of rimonabant on the high-triglyceride/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trialArterioscler Thromb Vasc Biol200929341642319112166
   PubMed Web of Science ®Google Scholar
• BabaSJaceneHAEnglesJMHondaHWahlRLCT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studiesJ Nucl Med201051224625020124047
   PubMed Web of Science ®Google Scholar
• TanWCHagueCJLeipsicJFindings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort StudyPLoS One20161111e016674527861566
   PubMed Web of Science ®Google Scholar
• LeeSSParkSHRadiologic evaluation of nonalcoholic fatty liver diseaseWorld J Gastroenterol201420237392740224966609
   PubMed Web of Science ®Google Scholar
• AlluriKJoshiPHHenryTSBlumenthalRSNasirKBlahaMJScoring of coronary artery calcium scans: history, assumptions, current limitations, and future directionsAtherosclerosis2015239110911725585030
   PubMed Web of Science ®Google Scholar
• SmithJDBorelALNazareJAVisceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA studyJ Clin Endocrinol Metab20129751517152522337910
   PubMed Web of Science ®Google Scholar
• MokraouiNMHaggertyJAlmirallJFortinMPrevalence of self-reported multimorbidity in the general population and in primary care practices: a cross-sectional studyBMC Res Notes2016931427315815
   PubMedGoogle Scholar
• AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar
• WanESHokansonJEMurphyJRClinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene studyAm J Respir Crit Care Med20111841576321493737
   PubMed Web of Science ®Google Scholar
• van RemoortelHHornikxMLangerDRisk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20141891303824219412
   PubMed Web of Science ®Google Scholar
• TroostersTSciurbaFBattagliaSPhysical inactivity in patients with COPD, a controlled multi-center pilot-studyRespir Med201010471005101120167463
   PubMed Web of Science ®Google Scholar
• HensonJEdwardsonCLMorganBAssociations of Sedentary Time with Fat Distribution in a High-Risk PopulationMed Sci Sports Exerc20154781727173425386715
   PubMed Web of Science ®Google Scholar
• PhilipsenAHansenALJørgensenMEAssociations of objectively measured physical activity and abdominal fat distributionMed Sci Sports Exerc201547598398925207926
   PubMed Web of Science ®Google Scholar
• DivoMJMartinezCHManninoDMAgeing and the epidemiology of multimorbidityEur Respir J20144441055106825142482
   PubMed Web of Science ®Google Scholar
• KatzJNChangLCSanghaOFosselAHBatesDWCan comorbidity be measured by questionnaire rather than medical record review?Med Care199634173848551813
   PubMed Web of Science ®Google Scholar
• SchnellKWeissCOLeeTThe prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008BMC Pulm Med2012122622695054
   PubMed Web of Science ®Google Scholar
• SinDDManSFSfpMWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609
   PubMed Web of Science ®Google Scholar
• VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
   PubMed Web of Science ®Google Scholar
• MarquisKMaltaisFDuguayVThe metabolic syndrome in patients with chronic obstructive pulmonary diseaseJ Cardiopulm Rehabil200525422623216056071
   PubMedGoogle Scholar
• BreyerMKSpruitMAHansonCKPrevalence of metabolic syndrome in COPD patients and its consequencesPLoS One201496e9801324950070
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
   PubMed Web of Science ®Google Scholar
• Cebron LipovecNScholsAMvan den BorstBSarcopenia in Advanced COPD Affects Cardiometabolic Risk Reduction by Short-Term High-intensity Pulmonary RehabilitationJ Am Med Dir Assoc201617981482027321867
   PubMed Web of Science ®Google Scholar
• MaddocksMShrikrishnaDVitorianoSSkeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPDEur Respir J20144451188119824993908
   PubMed Web of Science ®Google Scholar
• RoblesPGSussmanMSNaraghiAIntramuscular Fat Infiltration Contributes to Impaired Muscle Function in COPDMed Sci Sports Exerc20154771334134125373483
   PubMed Web of Science ®Google Scholar
• MoonSSLow skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010Endocr J2014611617024088600
   PubMed Web of Science ®Google Scholar
• WilliamsMCMurchisonJTEdwardsLDCoronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortalityThorax201469871872324473329
   PubMed Web of Science ®Google Scholar
• KelleyDEMckolanisTMHegaziRAKullerLHKalhanSCFatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistanceAm J Physiol Endocrinol Metab20032854E906E91612959938
   PubMed Web of Science ®Google Scholar
• Seppälä-LindroosAVehkavaaraSHäkkinenAMFat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal menJ Clin Endocrinol Metab20028773023302812107194
   PubMed Web of Science ®Google Scholar